Health and social care providers in Finland operate in a rapidly evolving environment and require advisors with experience and understanding of their business as well as the regulatory climate. The pending reform of the Finnish healthcare system, development towards patients’ freedom of choice and ease of access, ageing population, increasing role of private service providers within the sector, and the consolidating market that is attractive to private equity investors, all make the Finnish healthcare and social care sectors interesting. Our team has had leading roles in advising private equity investors and private healthcare and social care providers in recent key M&A transactions within the industry. Our team also has broad experience in advising private health and social care providers in their contractual and regulatory matters and other significant projects.
The transition towards more personalized treatments and the end of the single blockbuster drug era mean that all actors within pharma and health technology sectors are facing rapidly increasing legal complexity. Our team provides advisory on matters varying from regulatory questions to complex transactions.